Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-27 @ 10:55 PM
Study NCT ID:
NCT05295394
Status:
WITHDRAWN
Last Update Posted:
2022-04-12
First Post:
2019-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study
Sponsor:
Pedro Cahn
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-25
First Submit QC Date:
None
Study First Post Date:
2022-03-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-05
Last Update Post Date:
2022-04-12
Last Update Post Date Type:
ACTUAL